149 related articles for article (PubMed ID: 20705523)
1. The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice.
Martins DF; Rosa AO; Gadotti VM; Mazzardo-Martins L; Nascimento FP; Egea J; López MG; Santos AR
J Pain; 2011 Mar; 12(3):315-22. PubMed ID: 20705523
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action.
Mazzardo-Martins L; Martins DF; Stramosk J; Cidral-Filho FJ; Santos AR
Neuroscience; 2012 Dec; 226():411-20. PubMed ID: 23000630
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive properties of the hydroalcoholic extract and the flavonoid rutin obtained from Polygala paniculata L. in mice.
Lapa Fda R; Gadotti VM; Missau FC; Pizzolatti MG; Marques MC; Dafré AL; Farina M; Rodrigues AL; Santos AR
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):306-15. PubMed ID: 19281602
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
Vasdev N; Garcia A; Stableford WT; Young AB; Meyer JH; Houle S; Wilson AA
Bioorg Med Chem Lett; 2005 Dec; 15(23):5270-3. PubMed ID: 16202587
[TBL] [Abstract][Full Text] [Related]
5. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
6. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
Rosa AO; Kaster MP; Binfaré RW; Morales S; Martín-Aparicio E; Navarro-Rico ML; Martinez A; Medina M; García AG; López MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1549-56. PubMed ID: 18579278
[TBL] [Abstract][Full Text] [Related]
8. Spinal antinociception evoked by the triterpene 3beta, 6beta, 16beta-trihydroxylup-20(29)-ene in mice: evidence for the involvement of the glutamatergic system via NMDA and metabotropic glutamate receptors.
Longhi-Balbinot DT; Pietrovski EF; Gadotti VM; Martins DF; Facundo VA; Santos AR
Eur J Pharmacol; 2009 Nov; 623(1-3):30-6. PubMed ID: 19765585
[TBL] [Abstract][Full Text] [Related]
9. Anti-stress effects of a GSK-3β inhibitor, AR-A014418, in immobilization stress of variable duration in mice.
Bali A; Jaggi AS
J Basic Clin Physiol Pharmacol; 2017 Jul; 28(4):315-325. PubMed ID: 28590916
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of glutamatergic and GABAergic systems and protein kinase A pathway in the antinociceptive effect caused by p-methoxy-diphenyl diselenide in mice.
Pinto LG; Jesse CR; Nogueira CW; Savegnago L
Pharmacol Biochem Behav; 2008 Feb; 88(4):487-96. PubMed ID: 18023853
[TBL] [Abstract][Full Text] [Related]
11. AR-A014418 as a glycogen synthase kinase-3 inhibitor: anti-apoptotic and therapeutic potential in experimental spinal cord injury.
Tunçdemir M; Yıldırım A; Karaoğlan A; Akdemir O; Oztürk M
Neurocirugia (Astur); 2013; 24(1):22-32. PubMed ID: 23116585
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the involvement of ionotropic glutamatergic receptors on the antinociceptive effect of (-)-linalool in mice.
Batista PA; Werner MF; Oliveira EC; Burgos L; Pereira P; Brum LF; Santos AR
Neurosci Lett; 2008 Aug; 440(3):299-303. PubMed ID: 18579302
[TBL] [Abstract][Full Text] [Related]
13. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive properties of the hydroalcoholic extract, fractions and compounds obtained from the aerial parts of Baccharis illinita DC in mice.
Freitas CS; Baggio CH; Dos Santos AC; Mayer B; Twardowschy A; Luiz AP; Marcon R; Soldi C; Pizzolatti MG; Dos Santos EP; Marques MC; Santos AR
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):285-92. PubMed ID: 19281601
[TBL] [Abstract][Full Text] [Related]
15. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
Gould TD; Einat H; Bhat R; Manji HK
Int J Neuropsychopharmacol; 2004 Dec; 7(4):387-90. PubMed ID: 15315719
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GSK-3β on Behavioral Changes and Oxidative Stress in an Animal Model of Mania.
Dal-Pont GC; Resende WR; Varela RB; Menegas S; Trajano KS; Peterle BR; Quevedo J; Valvassori SS
Mol Neurobiol; 2019 Apr; 56(4):2379-2393. PubMed ID: 30027342
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
19. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid.
Rosa KA; Gadotti VM; Rosa AO; Rodrigues AL; Calixto JB; Santos AR
Neurosci Lett; 2005 Jun 10-17; 381(1-2):185-8. PubMed ID: 15882814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
